Source: Stem Cell Research and Therapy. Unidade: FMRP
Subjects: DIABETES MELLITUS, CITOCINAS, DIFERENCIAÇÃO CELULAR, PÂNCREAS, BAÇO
ABNT
YAOCHITE, Juliana Navarro Ueda et al. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties. Stem Cell Research and Therapy, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.1186/s13287-015-0261-4. Acesso em: 18 nov. 2024.APA
Yaochite, J. N. U., Lima, K. W. A. de, Callari-Oliveira, C., Palma, P. V. B., Couri, C. E. B., Simões, B. P., et al. (2016). Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties. Stem Cell Research and Therapy, 7. doi:10.1186/s13287-015-0261-4NLM
Yaochite JNU, Lima KWA de, Callari-Oliveira C, Palma PVB, Couri CEB, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KCR. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties [Internet]. Stem Cell Research and Therapy. 2016 ; 7[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s13287-015-0261-4Vancouver
Yaochite JNU, Lima KWA de, Callari-Oliveira C, Palma PVB, Couri CEB, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KCR. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties [Internet]. Stem Cell Research and Therapy. 2016 ; 7[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s13287-015-0261-4